Search | Clinical Trials Finder

Conditions: Endometriosis
Interventions: Ulipristal; Drug
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Endometriosis, Dysmenorrhea, Dyspareunia
Interventions: Norethindrone Acetate (NA), GnRH Agonist (Lupron Depot); Drug
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Endometriosis
Interventions: Estradiol/Norethindrone Acetate, Placebo for Elagolix, Elagolix, Placebo for E2/NETA; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 681 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 188
States / cities: Birmingham, Alabama • Fairhope, Alabama • Mobile, Alabama + 140 more

Conditions: Endometriosis
Interventions: Elagolix, Placebo, Combined Oral Contraceptive; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 49 Years · Female only
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 176
States / cities: Anniston, Alabama • Birmingham, Alabama • Dothan, Alabama + 134 more

Conditions: Endometriosis
Interventions: Relugolix, Estradiol/norethindrone acetate; Drug
Lead sponsor: Myovant Sciences GmbH; Industry
Eligibility: 18 Years to 51 Years · Female only
Enrollment: 802 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 60
States / cities: Andalusia, Alabama • Scottsdale, Arizona • Tucson, Arizona + 50 more

Conditions: Dysmenorrhea
Interventions: Naproxen Sodium, (Aleve, BAY117031), Acetaminophen (Tylenol Extra Strength); Drug
Lead sponsor: Bayer; Industry
Eligibility: 15 Years to 35 Years · Female only
Enrollment: 201 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 8
States / cities: Chandler, Arizona • Scottsdale, Arizona • Pinellas Park, Florida + 5 more

Conditions: Period Pain
Interventions: Magnet; Device
Lead sponsor: Nova Southeastern University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Davie, Florida

Conditions: Dysmenorrhea, Dysmenorrhea Primary, Visceral Pain, Menstrual Pain
Interventions: Visceral Pain Stimulus; Diagnostic Test
Lead sponsor: Azusa Pacific University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Azusa, California

Conditions: PMS, Menstrual Pain
Interventions: Elix Cycle Balance; Dietary Supplement
Lead sponsor: Zenchi, Inc.; Industry
Eligibility: 18 Years to 36 Years · Female only
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Dysmenorrhea, Pain
Interventions: Naproxen; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Dysmenorrhea
Interventions: levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets, Placebo tablet; Drug
Lead sponsor: Duramed Research; Industry
Eligibility: Up to 17 Years · Female only
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 13
States / cities: Denver, Colorado • Decatur, Georgia • Louisville, Kentucky + 10 more

Conditions: Soft Tissue Injuries, Gouty Arthritis, Fractures, Ureteral Colic, Dysmenorrhea
Interventions: Not listed
Lead sponsor: Radnor Registry Research, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 843 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 11
States / cities: Birmingham, Alabama • New Orleans, Louisiana • Jackson, Mississippi + 5 more

Conditions: Dysmenorrhea, Chronic Pelvic Pain, Pelvic Pain
Interventions: Naproxen Sodium 550mg, Placebo, Extended Release Acetaminophen (650 mg); Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Dysmenorrhea, Menstrual Pain
Interventions: Sildenafil citrate vaginal suppository, Placebo vaginal suppository; Drug
Lead sponsor: Kevin Hellman; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Dysmenorrhea (Disorder), Dysmenorrhea Primary, Dysmenorrhea Secondary, Endometrial Diseases, Leiomyoma, Fibroid Uterus
Interventions: Naproxen Sodium; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 183 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Dysmenorrhea Primary
Interventions: Osteopathic manipulative medicine; Procedure
Lead sponsor: New York Institute of Technology; Other
Eligibility: 18 Years and older · Female only
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Old Westbury, New York

Conditions: Dysmenorrhea Primary, Dysmenorrhea, Menstrual Discomfort, Menstrual Problem, Menstrual Cycle Abnormal, Menstrual Pain, Period Pain, Period Problem, PMS, Premenstrual Syndrome, PCOS, PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, PCOS (Polycystic Ovary Syndrome) of Left Ovary, PCOS (Polycystic Ovary Syndrome) of Right Ovary, Polycystic Ovary Syndrome, Premenstrual Dysphoric Disorder, Cramps, Ovarian Cysts
Interventions: Cramp Bites by Aunt Flo's Kitchen; Dietary Supplement
Lead sponsor: Cornell University; Other
Eligibility: 18 Years to 25 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Ithaca, New York

Conditions: Menstrual Distress (Dysmenorrhea)
Interventions: No Intervention, Sham Logan Basic Adjustment, Logan Basic adjustment; Other · Procedure
Lead sponsor: Logan College of Chiropractic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Chesterfield, Missouri

Conditions: Menstrual Pain, Premenstrual Syndrome
Interventions: Pamprin Botanicals, Pamprin Botanicals + Pamprin Menstrual Pain Relief; Other · Combination Product
Lead sponsor: Focus Consumer Healthcare; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Santa Monica, California

Conditions: Womens Health, Menstrual Symptoms
Interventions: Effera® (human equivalent lactoferrin), Placebo; Dietary Supplement · Other
Lead sponsor: Helaina Inc.; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Premenstrual Syndrome, Menstrual Pain
Interventions: DITTO Cycle Supplement; Dietary Supplement
Lead sponsor: Muse Nutrition Ltd; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Endometriosis
Interventions: Placebo, OBE2109; Drug
Lead sponsor: ObsEva SA; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 328 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 71
States / cities: Chandler, Arizona • Scottsdale, Arizona • Arcadia, California + 59 more

Conditions: Uterine Fibroids, Leiomyoma, Menstrual Pain
Interventions: Elix Daily Harmony; Dietary Supplement
Lead sponsor: Zenchi, Inc.; Industry
Eligibility: 20 Years to 45 Years · Female only
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Dysmenorrhea
Interventions: levonorgestrel/EE 0.15/0.03 and EE 0.01 mg tablets, levonorgestrel/EE 0.15/0.03 mg tablets and placebo; Drug
Lead sponsor: Duramed Research; Industry
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 18
States / cities: Huntsville, Alabama • Phoenix, Arizona • San Diego, California + 14 more

Search by objective public record fields.

Ulipristal for Endometriosis-related Pelvic Pain

Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain

SPIRIT EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Endometriosis-Associated Pain

A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea

Impacts of Static Magnetic Fields on Dysmenorrhea Pain

A Research Study Exploring How Musculoskeletal Function and the Autonomic Nervous System Relate to Visceral Pain in Women With and Without Dysmenorrhea (Painful Periods).

Study to Evaluate the Efficacy of Elix's Cycle Balance and Its Impact on PMS and Menstrual Symptoms

Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain

AMPED Outcomes Registry of Post-ED Pain Management

NSAID Use for Treating Dysmenorrhea and Preventing Chronic Pelvic Pain (NSAID HEAL)

Vaginal Sildenafil for Primary Dysmenorrhea

Mechanistic Characterization of Uterine Pain

The Effect of OMM in the Treatment of Primary Dysmenorrhea Symptoms

Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25

Logan Basic and Dysmenorrhea

An Investigation Into the Efficacy of a Botanical Supplement to Provide Period Relief

Effera Dose Response: Women's Health

A Clinical Study to Assess the Effect of a Dietary Supplement on Menstrual Cycle Symptoms

A Study to Assess the Efficacy and Safety of OBE2109 in Subjects With Endometriosis

An Open-Label Study to Evaluate the Effect of Elix Cycle Balance & Elix Daily Harmony on Fibroid-related Symptoms

A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain